Saint Luke's Cancer Institute 150 Entrance — Kansas City, Missouri

Saint Luke's Cancer Institute 150 Entrance is a clinical research site located in Kansas City, Missouri, United States 63376.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Saint Luke's Cancer Institute 150 Entrance has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Locally Recurrent Breast Cancer.

Sponsors: Spexis AG.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Cancer Institute 150 Entrance?

Saint Luke's Cancer Institute 150 Entrance has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Cancer Institute 150 Entrance conducted?

Saint Luke's Cancer Institute 150 Entrance has 1 clinical trials on record. Their work covers Metastatic Breast Cancer, Locally Recurrent Breast Cancer.

Is Saint Luke's Cancer Institute 150 Entrance accredited by Crixeo Health?

Saint Luke's Cancer Institute 150 Entrance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Luke's Cancer Institute 150 Entrance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.